About the Alzheimer's Drug Discovery Foundation (ADDF)
ADDF (www.alzdiscovery.org) is the only public charity whose sole mission is to accelerate the discovery and development of drugs to prevent, treat and cure Alzheimer's disease, related dementias and cognitive aging. We award grants to leading scientists conducting breakthrough drug discovery research. ADDF uses a venture philanthropy model to bridge the worldwide funding gap between basic research and later-stage development, using any return on investment to support new research. Since 1998, we have received over 1,600 requests to fund new ideas for Alzheimer's drugs. For all, we provided expert reviews and recommendations to advance their programs. We granted more than $35M to fund over 240 Alzheimer's drug discovery programs in academic centers and biotechnology companies in 12 countries. The ADDF website carries the latest, vetted news on Alzheimer's disease, updated weekly.
About the Lewy Body Dementia Association (LBDA)
LBDA is the only organization in the United States that provides comprehensive information, education and support for the 1.5 million people afflicted by Lewy body dementias. LBDA's Scientific Advisory Council (SAC) is comprised of leading experts in research and clinical management of Lewy body dementias from the United States, Canada, the United Kingdom and Japan. To learn more about LBDA, visit www.lbda.org
|SOURCE Alzheimer's Drug Discovery Foundation|
Copyright©2009 PR Newswire.
All rights reserved